Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Squalene synthase inhibition: a novel target for the management of dyslipidemia.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Squalene synthase inhibition: a novel target for the management of dyslipidemia.
Squalene synthase inhibition: a novel target for the management of dyslipidemia. Curr Atheroscler Rep. 2007 Jan; 9(1):78-80.
View in:
PubMed
subject areas
Clinical Trials, Phase III as Topic
Drug Delivery Systems
Dyslipidemias
Farnesyl-Diphosphate Farnesyltransferase
Humans
Oxazepines
Piperidines
authors with profiles
Michael H. Davidson